                                  DC REGULATIONS

ADMINISTRATION OF THERAPEUTIC PHARMACEUTICAL AGENTS (§ 17-6413)

6413.1. As used in this section, the term &#8220;therapeutic pharmaceutical
   agents&#8221; means appropriate topical drugs and oral systemic drugs,
   including antibiotics, appropriate analgesics, antihistamines, non-steroidal
   anti-inflammatories, and anti-glaucoma medications. The term
   &#8220;therapeutic pharmaceutical agents&#8221; includes topical steroidal
   anti-inflammatories and antivirals, or oral medications for the emergency
   treatment of angle closure glaucoma. The term &#8220;therapeutic
   pharmaceutical agents&#8221; does not include oral and injectable antiviral
   and antifungal agents and other oral and injectable agents not authorized in
   this section, except for an injectable to counter an anaphylactic reaction.

   6413.2. Only an optometrist certified pusuant to this section may administer
   therapeutic pharmaceutical agents.

   6413.3. An applicant for certification to administer therapeutic
   pharmaceutical agents shall do the following:
   
   
   
   (a)	Submit a completed, notarized application and pay the fee provided in
   Chapter 35 of this title; and
   
   
   
   (b)	Demonstrate to the satsfaction of the Board that he or she:
   
   
   
   (1)	Has either applied for licensure under this chapter as an optometrist, or
   has been is-sued a license under this chapter as an optometrist;
   
   
   
   (2)	If a graduate of an accredited school of optometry prior to July 1, 1992,
   has completed a Board approved course consisting of a minimum of one hundred
   (100) clock hours in general and ocular pharmacology which meets the
   requirements of § 207 of the Act, D.C. Code § 2-3302.7, and has arranged for
   the institution to transmit a transcript of the courses taken directly to the
   Board; and
   
   
   
   (3)	Has passed the treatment and management of ocular disease (TMOD) section
   of the examination administered by the National Board of Examiners in
   Optometry, or any other examination approved by the National Board of
   Examiners in Optometry or the Board, has arranged for the test results to be
   submitted directly to the Board.

   6413.4. A course approved by the Board shall be any course in the treatment
   and management of ocular disease offered or approved by an accredited school
   of optometry.

   6413.5. An optometrist certified pursuant to this section shall not administer
   a therapeutic pharmaceutical agent when the medical condition of the patient
   contraindicates such use.

   6413.6. Prior to initiating treatment for glaucoma, an optometrist shall
   consult with the patient&#8217;s physician or other appropriate health
   professional. The treatment of angle closure glaucoma shall be limited to the
   initiation of immediate emergency treatment.
   
   
   
   
   
   
   
   	An optometrist certified for the administration of therapeutic pharmaceutical
   agents shall prove to the Board’s satisfaction that he or she has completed
   six (6) hours of approved continuing education credits pursuant to section
   6408.
   
   
   
   	SOURCE: Final Rulemaking published at 46 DCR 4197 (May 7, 1999); as amended
   by Notice of Final Rulemaking published at 59 DCR 2157, 2158 (March 16, 2012).
